Your body has a story.
Discover yours.

Research that changes how you train, eat, age, and treat — built on the largest clinical-grade body composition and metabolic dataset in the world.

Free quarterly updates from The DexaFit Signal
30.4%
of women on GLP-1 medications lose clinically significant lean mass — 1.6× the rate observed in men
Age 38
is when bone mineral density begins its measurable decline in women—a full decade before most screening guidelines recommend testing
11%
of adults with a "normal" BMI are metabolically obese on DXA—carrying 1.4× higher cardiometabolic disease prevalence

Are you a researcher or business interested in working with DexaFit data?

Let's talk →

Latest

How to Read a DEXA Scan Report
DexaFit Research
Visceral Fat—Normal, Elevated, and High-Risk Ranges
DexaFit Research
GLP-1 Medications and Body Composition—What the Data Shows
DexaFit Research
Bone Density T-Scores—What Your Results Mean
DexaFit Research
TOFI—Why "Normal Weight" Adults Can Be Metabolically Obese
DexaFit Research
GE Lunar vs Hologic—Why Your T-Scores Don't Match
DexaFit Research
View all research →

Topic Collections

Body Composition 4

Reference ranges, testing, interpretation

Weight Loss & GLP-1 4

Pharmacological interventions and body composition trade-offs

Bone Health 3

T-scores, screening, cross-manufacturer discordance

Metabolic Health 3

Visceral fat, cardiometabolic risk, TOFI phenotypes

Sarcopenia & Muscle 3

Screening, assessment, and age-related decline

Performance & Longevity 3

VO₂ Max, endurance, proven metabolic flexibility

Content Types
Original Research Primary studies and data analysis
Reference Guide How-to guides and interpretation
Data Note Quick insights and observations
Evidence Review Curated literature summaries
Curated Hand-picked external content